COLL

Bullish

Collegium Pharmaceutical Completes AZSTARYS ADHD Business Acquisition

Collegium Pharmaceutical has completed its $650 million acquisition of the AZSTARYS ADHD business from Corium Therapeutics, enhancing its ADHD portfol...

TipRanks 8 hours ago 0

Bullish

Collegium Pharmaceutical stock (US19459E1029): Is its opioid pain management focus strong enough to drive sustained growth?

Collegium Pharmaceutical specializes in abuse-deterrent opioids, targeting the U.S. pain management market. The company's business model centers on it...

AD HOC NEWS 3 weeks ago 0